Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A F Lever

Showing results (181-190 of 278) with videos related to

Pageof 28
Sort By:
Clinical Science and Molecular Medicine. Supplement|August 1, 1973
Spironolactone and amiloride in the treatment of low renin hyperaldosteronism and related syndromesD Kremer, D G Beevers, J J Brown, et al.
Journal of Human Hypertension|June 1, 1987
Severe hypertension with absent secondary sex characteristics due to partial deficiency of steroid 17 alpha-hydroxylase activityR Fraser, J J Brown, P A Mason, et al.
British Journal of Clinical Pharmacology|June 1, 1982
Captopril treatment: inter-dose variations in renin, angiotensins I and II, aldosterone and blood pressureA B Atkinson, A M Cumming, J J Brown, et al.
Lancet (London, England)|June 5, 1976
Mechanism of renal hypertensionJ J Brown, D L Davies, J J Morton, et al.
Lancet (London, England)|September 22, 1979
Hyponatraemic hypertensive syndrome with renal-artery occlusion corrected by captoprilA B Atkinson, D L Davies, B Leckie, et al.
Australian and New Zealand Journal of Medicine|August 1, 1976
The effects of saralasin, an angiotensin II antagonist, on blood pressure and the renin-angiotensin-aldosterone system in normal and hypertensive subjectsJ J Brown, W C Brown, R Fraser, et al.
British Medical Journal (Clinical Research Ed.)|December 11, 1982
Converting-enzyme inhibitor enalapril (MK421) in treatment of hypertension with renal artery stenosisG P Hodsman, J J Brown, D L Davies, et al.
Hypertension (Dallas, Tex. : 1979)|May 1, 1981
Response of aldosterone and 18-hydroxycorticosterone to angiotensin II in normal subjects and patients with essential hypertension, Conn's syndrome, and nontumorous hyperaldosteronismR Fraser, C Beretta-Piccoli, J J Brown, et al.
Lancet (London, England)|July 5, 1980
Neurological dysfunction in two patients receiving captopril and cimetidineA B Atkinson, J J Brown, A F Lever, et al.
Circulation|July 15, 1997
Abnormal epinephrine release in young adults with high personal and high parental blood pressuresS B Harrap, R Fraser, G C Inglis, et al.
Pageof 28

Showing results (181-190 of 278) with videos related to

Sort By:
Pageof 28
Clinical Science and Molecular Medicine. Supplement|August 1, 1973
Spironolactone and amiloride in the treatment of low renin hyperaldosteronism and related syndromesD Kremer, D G Beevers, J J Brown, et al.
Journal of Human Hypertension|June 1, 1987
Severe hypertension with absent secondary sex characteristics due to partial deficiency of steroid 17 alpha-hydroxylase activityR Fraser, J J Brown, P A Mason, et al.
British Journal of Clinical Pharmacology|June 1, 1982
Captopril treatment: inter-dose variations in renin, angiotensins I and II, aldosterone and blood pressureA B Atkinson, A M Cumming, J J Brown, et al.
Lancet (London, England)|June 5, 1976
Mechanism of renal hypertensionJ J Brown, D L Davies, J J Morton, et al.
Lancet (London, England)|September 22, 1979
Hyponatraemic hypertensive syndrome with renal-artery occlusion corrected by captoprilA B Atkinson, D L Davies, B Leckie, et al.
Australian and New Zealand Journal of Medicine|August 1, 1976
The effects of saralasin, an angiotensin II antagonist, on blood pressure and the renin-angiotensin-aldosterone system in normal and hypertensive subjectsJ J Brown, W C Brown, R Fraser, et al.
British Medical Journal (Clinical Research Ed.)|December 11, 1982
Converting-enzyme inhibitor enalapril (MK421) in treatment of hypertension with renal artery stenosisG P Hodsman, J J Brown, D L Davies, et al.
Hypertension (Dallas, Tex. : 1979)|May 1, 1981
Response of aldosterone and 18-hydroxycorticosterone to angiotensin II in normal subjects and patients with essential hypertension, Conn's syndrome, and nontumorous hyperaldosteronismR Fraser, C Beretta-Piccoli, J J Brown, et al.
Lancet (London, England)|July 5, 1980
Neurological dysfunction in two patients receiving captopril and cimetidineA B Atkinson, J J Brown, A F Lever, et al.
Circulation|July 15, 1997
Abnormal epinephrine release in young adults with high personal and high parental blood pressuresS B Harrap, R Fraser, G C Inglis, et al.
Pageof 28